The Ki67 positive rate was decreased under abiraterone acetate treatment and was lowest in abiraterone acetate+miR-143 tumor tissues among four groups, confirming that miR-143 promotes tumor inhibition effect of abiraterone acetate on PC3-AbiR cells (Figure 6). Here, MKI67 is linked to neoplasm.